Browsing by Contributors Brady, William E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
Showing results 1 to 3 of 3
PreviewIssue DateTitleContributor(s)
2017 GynecologyOncology Volume 147 Issue 2 November (3).pdf.jpg2017An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experienceOliver, Kate E.; Brady, William E.; Birrer, Michael; Gershenson, David M.; Fleming, Gini; Copeland, Larry J.; Tewari, Krishnansu; Argenta, Peter a.; Mannel, Robert S.; Secord, Angeles Alvarez; Stephan, Jean Marie; Mutch, David G.; Stehman, Frederick B.; Muggia, Franco
GYNONC 2017 Voluem 145 Issue 2 May (28).pdf.jpg2017A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyJandial, Danielle a.; Brady, William E.; Howell, Stephen B.; Lankes, Heather a.; Schilder, Russell J.; Beumer, Jan H.; Christner, Susan M.; Strychor, Sandra; Powell, Matthew a.; Hagemann, Andrea R.; Moore, Kathleen N.; Walker, Joan L.; DiSilvestro, Paul a.; Duska, Lin
2017 GynecologyOncology Volume 147 Issue 2 November (5).pdf.jpg2017A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritonealThaker, Premal H.; Brady, William E.; Lankes, Heather a.; Odunsi, Kunle; Bradley, William H.; Moore, Kathleen N.; Muller, Carolyn Y.; Anwer, Khursheed; Schilder, Russell J.; Alvarez, Ronald D.; Fracasso, Paula M.